Dr. Hanley had significant holdings during her time at Viking Therapeutics. In 2019, she executed multiple insider trades, with values fluctuating around $1 million each month, indicating a strong presence in the company's stock. Her holdings peaked in early 2024,...

Dr. Hanley had significant holdings during her time at Viking Therapeutics. In 2019, she executed multiple insider trades, with values fluctuating around $1 million each month, indicating a strong presence in the company's stock. Her holdings peaked in early 2024, where she had a remarkable $11.95 million in stock holdings, showing confidence in the company's future. However, after her resignation, the fluctuations were less frequent, hinting at a strategic management of her investments in the company. This level of insider activity suggests she actively managed her investments based on her insights into the company's performance and stock value. That activity transitioned vividly over time, reflecting confidence and eventual withdrawal from her direct involvement in decision-making at Viking.